3 Rallying Drug-Makers Being Snapped Up By Insiders
Kapitall
•
Fri, Jun 22, 2012
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
Marketwire (Jun 5, 2012)
-
Marketwire (May 30, 2012)
-
10 Stocks With Recent Negative EPS Surprises And Broker DowngradesVytautas Drumelis • Tue, May 15, 2012 -
-
-
Marketwire (May 7, 2012)
-
-
-
AstraZeneca Sprinting To Fix ItselfStephen Simpson • Thu, Apr 26, 2012 -
Noteworthy Institutional 5% Ownership Filings In The Past WeekGuruFundPicks • Wed, Apr 25, 2012
-
Rare Disease Stocks With Takeover PotentialJessica King Holden • Tue, Apr 24, 2012 -
-
-
-
-
14 Undervalued Stocks Backed By Insider BuyingKapitall • Thu, Dec 29, 2011
To learn more about Seeking Alpha Pro, click here.
-
Ardea's Gout Drug ProgressesDerek Lowe • Thu, Apr 1, 2010
-
3 Rallying Drug-Makers Being Snapped Up By InsidersKapitall • Fri, Jun 22, 2012
-
-
-
10 Stocks With Recent Negative EPS Surprises And Broker DowngradesVytautas Drumelis • Tue, May 15, 2012
-
-
-
-
-
AstraZeneca Sprinting To Fix ItselfStephen Simpson • Thu, Apr 26, 2012
-
Noteworthy Institutional 5% Ownership Filings In The Past WeekGuruFundPicks • Wed, Apr 25, 2012
-
Rare Disease Stocks With Takeover PotentialJessica King Holden • Tue, Apr 24, 2012
-
-
-
-
-
14 Undervalued Stocks Backed By Insider BuyingKapitall • Thu, Dec 29, 2011
-
-
-
-
There are no Transcripts on RDEA.
-
Marketwire (Jun 5, 2012)
-
Marketwire (May 30, 2012)
-
Marketwire (May 7, 2012)
-
at MarketWatch.com (Apr 23, 2012)
-
at MarketWatch.com (Apr 23, 2012)
-
at CNBC.com (Apr 23, 2012)
-
Marketwire (Dec 19, 2011)
RDEA vs. ETF Alternatives
Company Description
Currently, there's no company description for RDEA.
